The Recombinant Vaccines Market Growth was valued at USD 9.18 billion in 2022. It is projected to reach USD 21.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2% during the forecast period from 2023 to 2030.
Recombinant Vaccines have emerged as a significant player in the pharmaceutical industry, offering promising solutions for preventing and...
Dutch 
English
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
urdu